Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

17.82
Delayed Data
As of Apr 20
 +0.11 / +0.62%
Today’s Change
10.85
Today|||52-Week Range
33.82
-5.96%
Year-to-Date

Stock Price Forecast

The 24 analysts offering 12-month price forecasts for Teva Pharmaceutical Industries Ltd have a median target of 18.00, with a high estimate of 24.00 and a low estimate of 11.00. The median estimate represents a +1.01% increase from the last price of 17.82.

Analyst Recommendations

The current consensus among 30 polled investment analysts is to Hold stock in Teva Pharmaceutical Industries Ltd. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.71
Sales
$4.9B
Reporting Date
May 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -23.99%
 
 
 
 
 
 
Growthannually -39.70%
 
 
 
 
 
 

Sales

Growthquarterly -10.61%
 
 
 
 
 
 
Growthannually -16.89%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.